MAPT and Alzheimer disease: Fiandaca et al., 2015 [113] measured the levels of pathogenic proteins in the blood of patients with AD, including total tau, P-T181-tau, P–S396-tau, and Aβ1-42 in neuron-derived EXOs (NDEs).